Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Aminoglycoside- and glycopeptide-induced ototoxicity in children: a systematic review.
Diepstraten FA, Hoetink AE, van Grotel M, Huitema ADR, Stokroos RJ, van den Heuvel-Eibrink MM, Meijer AJM. Diepstraten FA, et al. Among authors: hoetink ae. JAC Antimicrob Resist. 2021 Dec 14;3(4):dlab184. doi: 10.1093/jacamr/dlab184. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34917943 Free PMC article. Review.
Tinnitus during and after childhood cancer: A systematic review.
Meijer AJM, Clemens E, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM. Meijer AJM, et al. Among authors: hoetink ae. Crit Rev Oncol Hematol. 2019 Mar;135:1-7. doi: 10.1016/j.critrevonc.2019.01.004. Epub 2019 Jan 11. Crit Rev Oncol Hematol. 2019. PMID: 30819438
Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study.
Meijer AJM, Fiocco MF, Janssens GO, Clemens E, Tissing WJE, Loonen JJ, van Dulmen-den Broeder E, de Vries ACH, Bresters D, Versluys B, Ronckers CM, Kremer LCM, van der Pal HJ, Neggers SJCMM, van der Heiden-van der Loo M, Stokroos RJ, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM. Meijer AJM, et al. Among authors: hoetink ae. Neurooncol Adv. 2020 Sep 15;2(1):vdaa122. doi: 10.1093/noajnl/vdaa122. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 33196041 Free PMC article.
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.
Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE Consortium; and the CPNDS Consortium. Meijer AJM, et al. Among authors: hoetink ae. NPJ Precis Oncol. 2021 Jul 14;5(1):64. doi: 10.1038/s41698-021-00178-z. NPJ Precis Oncol. 2021. PMID: 34262104 Free PMC article.
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.
Meijer AJM, van den Heuvel-Eibrink MM, Brooks B, Am Zehnhoff-Dinnesen AG, Knight KR, Freyer DR, Chang KW, Hero B, Papadakis V, Frazier AL, Blattmann C, Windsor R, Morland B, Bouffet E, Rutkowski S, Tytgat GAM, Geller JI, Hunter LL, Sung L, Calaminus G, Carleton BC, Helleman HW, Foster JH, Kruger M, Cohn RJ, Landier W, van Grotel M, Brock PR, Hoetink AE, Rajput KM; Society of Paediatric Oncology Supportive Care Committee. Meijer AJM, et al. Among authors: hoetink ae. JAMA Oncol. 2021 Oct 1;7(10):1550-1558. doi: 10.1001/jamaoncol.2021.2697. JAMA Oncol. 2021. PMID: 34383016
The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.
Meijer AJM, Li KH, Brooks B, Clemens E, Ross CJ, Rassekh SR, Hoetink AE, van Grotel M, van den Heuvel-Eibrink MM, Carleton BC. Meijer AJM, et al. Among authors: hoetink ae. Cancer. 2022 Jan 1;128(1):169-179. doi: 10.1002/cncr.33848. Epub 2021 Sep 7. Cancer. 2022. PMID: 34490624 Free article.
Patterns of Hearing Loss in Irradiated Survivors of Head and Neck Rhabdomyosarcoma.
Diepstraten FA, Wiersma J, Schoot RA, Knops RRG, Zuur CL, Meijer AJM, Dávila Fajardo R, Pieters BR, Balgobind BV, Westerveld H, Freling N, van Tinteren H, Smeele LE, Bel A, van den Heuvel-Eibrink MM, Stokroos RJ, Merks JHM, Hoetink AE, Hol MLF. Diepstraten FA, et al. Among authors: hoetink ae. Cancers (Basel). 2022 Nov 23;14(23):5749. doi: 10.3390/cancers14235749. Cancers (Basel). 2022. PMID: 36497230 Free PMC article.
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment.
Fernandez K, Hoetink A, Konrad-Martin D, Berndtson D, Clark K, Dreisbach L, Geller JI, Goffi-Gomez MV, Grosnik A, Jamis C, Knight K, Lee DS, Lee J, Liberman PHP, Milnes T, Meijer AJM, Ortiz CE, Rooker J, Sanchez VA, van den Heuvel-Eibrink MM, Brewer CC, Poling GL. Fernandez K, et al. Ear Hear. 2024 Sep 12. doi: 10.1097/AUD.0000000000001592. Online ahead of print. Ear Hear. 2024. PMID: 39261989
The association between skeletal muscle mass and sensorineural hearing loss upon cisplatin-based chemoradiotherapy in patients with head and neck squamous cell carcinoma.
Schaeffers AWMA, Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, van der Molen L, Hoetink AE, Al-Mamgani A, Jóźwiak K, Devriese LA, de Bree R, Zuur CL. Schaeffers AWMA, et al. Among authors: hoetink ae. Head Neck. 2024 Aug 2. doi: 10.1002/hed.27907. Online ahead of print. Head Neck. 2024. PMID: 39096016
18 results